Meridian Bioscience, Inc. (VIVO) Release: PCR From Whole Blood, Simplified
11/14/2013 9:24:41 AM
CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the MyTaqTM Blood-PCR Kit, developed for fast, highly-specific PCR direct from whole blood samples.
Help employers find you! Check out all the jobs and post your resume.